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Summary 24 
Hepatitis C virus (HCV) is a human hepatotropic virus but many hepatoma cell lines are not 25 
permissive to this virus. In a previous study, we observed that SNU-182, SNU-398 and SNU-26 
449 hepatoma cell lines were non-permissive to HCV. In order to understand the non-27 
permissivity, we evaluated the ability of each cell line to support the different steps of HCV 28 
life cycle (entry, replication and production of infectious particles). Using retroviral 29 
pseudoparticles pseudotyped with HCV envelope proteins and recombinant HCV produced in 30 
cell culture, we observed that low level or absence of claudin-1 expression limited the viral 31 
entry process in SNU-182 and SNU-398 cells, respectively. Our results also showed that 32 
supplementation of the three cell lines with miR-122 partly restored the replication of a JFH1 33 
HCV replicon. Finally, we observed that expression of apolipoprotein E was very low or 34 
undetectable in the three cell lines and that its ectopic expression permits the production of 35 
infectious viral particles in SNU-182 and SNU-398 cells but not in SNU-449 cells. 36 
Nevertheless, the supplementation of SNU-182, SNU-398 and SNU-449 cells with claudin-1, 37 
miR-122 and apolipoprotein E was not sufficient to render these cells as permissive as HuH-7 38 
cells. Thus, these cell lines could serve as cell culture models for functional studies on the role 39 
of claudin-1, miR-122 and apolipoprotein E in HCV life cycle but also for the identification 40 
of new restriction and/or dependency host factors essential for HCV infection. 41 
 42 
Keywords : ApoE, CLDN1, Hepatitis C virus, miR-122, restriction and dependency factors. 43 
 44 
Abbreviations : HCV, Hepatitis C virus; HCVpp, retroviral particles pseudotyped with HCV 45 
envelope proteins; HCVcc, recombinant HCV produced in cell culture; SR-BI, Scavenger 46 
receptor class B type I; CLDN1, claudin-1; OCLN, occludin; NPC1L1, Niemann–Pick C1-47 
like 1; ApoE, Apolipoprotein E. 48 
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1 | INTRODUCTION 50 
 Hepatitis C virus (HCV) is an important human pathogen. Worldwide, over 170 51 
million people are chronically infected. Furthermore, 75% to 80% of HCV-infected patients 52 
develop chronic infection, which may lead to cirrhosis and, ultimately, hepatocellular 53 
carcinoma. HCV is a small enveloped positive-strand RNA virus of the Flaviviridae family, 54 
classified in the Hepacivirus genus (1). 55 
 The study of HCV infection has long been limited by the absence of complete in vitro 56 
cell culture system. However, several alternative tools were developed in the two past decades 57 
to understand the HCV life cycle. First, the establishment of subgenomic replicons that 58 
autonomously amplify in cultured human hepatoma cells allowed to understand the 59 
mechanisms of HCV genome replication (2). Then, the generation of infectious retroviral 60 
pseudotypes displaying functional HCV glycoproteins (HCVpp) allowed for the study of 61 
HCV entry (3, 4). The cloning of the genotype 2a JFH1 strain finally paved the way for the 62 
production of infectious HCV virions (HCVcc) and the investigation of the full viral cycle in 63 
human liver cancer-derived HuH-7 cells (5, 6). Thanks to these models, substantial progress 64 
has been made in the identification of host factors involved in HCV propagation. Among 65 
them, CD81, the scavenger receptor class B type I (SR-BI), claudin-1 (CLDN1) occludin 66 
(OCLN) and NPC1L1 were identified as important HCV entry factors (7). The liver-specific 67 
microRNA miR-122 has been shown to be one of the most important host factors for HCV 68 
replication (8). Furthermore, components of the very low density lipoprotein biosynthesis 69 
pathway such as apolipoprotein E (ApoE) have been shown to be important for the assembly 70 
and release of infectious viral particles (9-12). 71 
 The use of non-permissive cells is an interesting tool to identify new host restriction or 72 
dependency factors for viral permissivity. In a previous study, we reported that the SNU-182, 73 
SNU-398 and SNU-449 hepatocarcinoma cell lines were not able to support HCV infection 74 
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(13). In this work, we evaluated the ability of each cell line to support specific steps of HCV 75 
lifecycle (i.e. entry, replication and production of infectious particles) and tried to identify the 76 
host factors that prevent these cell lines from being infected by this virus. 77 
 78 
2 | MATERIALS AND METHODS 79 
2.1 | Cell culture 80 
SNU-182 (CRL-2235), SNU-398 (CRL-2233) and SNU-449 (CRL-2234) cell lines (14) were 81 
obtained from ATCC. We also used the HuH-7 (RCB1366) (15) and HEK293T (CRL-11268) 82 
cell lines as control cells. All cell lines were cultured in Glutamax®-supplemented DMEM 83 
containing 10% fetal bovine serum. 84 
 85 
2.2 | HCV Virus 86 
We used two recombinant viruses derived from the JFH1 strain and expressing a Renilla 87 
luciferase reporter gene, the JFH1-CS-A4-RLuc/TM construct (13) and the JFH1-CS-A4-88 
RLuc/QM construct which contain the additional mutation I414T in E2, as compared to the 89 
JFH1-CS-A4-RLuc/TM strain. 90 
 91 
2.3 | HCVcc and HCVpp infection 92 
HuH-7, SNU-182, SNU-398 and SNU-449 cells were inoculated for 3 hours with JFH1-93 
derived constructs expressing the luciferase reporter gene. After inoculation, the medium was 94 
changed and cells were cultured for 72 hours. HCV infection was assessed by measuring the 95 
luciferase activity with a Berthold CentroXS3 LB 960 luminometer. HCV entry in HuH-7, 96 
SNU-182, SNU-398, SNU-449 and 293T cells was evaluated using retroviral particles 97 
expressing firefly luciferase and pseudotyped with HCV JFH1 E1/E2 glycoproteins (HCVpp) 98 
(3). Non-infected cells or cells inoculated with particles lacking envelope protein (Δenv) were 99 
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used as negative controls. Inoculation were performed during 3 hours and luciferase were 100 
measured 48 hours later. 101 
 102 
2.4 | Quantification of miR-122 expression 103 
The expression of miR-122-5p (assay ID: 002245) was quantified by RT-qPCR using the 104 
TaqMan® Small RNA Assays (Life Technologies), after extraction using the mirVanaTM 105 
miRNA Isolation Kit (Life Technologies), according to the manufacturer’s instructions. The 106 
small nuclear RNA RNU6B (assay ID: 001093) was used as endogenous control. The ΔΔCt 107 
method was used with HuH-7 cells as calibrator. 108 
 109 
2.5 | Flow cytomety. The CD81 cell surface expression was assessed by flow cytometry. 110 
Cells were trypsinized, centrifuged, resuspended in PBS and stained with isotype control or 111 
FITC-coupled anti-CD81 mouse monoclonal antibody (JS-81, BD Pharmingen). Samples 112 
were analyzed on a Navios flow cytometer (Beckman Coulter). 113 
 114 
2.6 | CLDN1, ApoE and miR-122 transductions. Lentiviral pseudoparticles were generated 115 
by co-transfection of 293T cells with plasmids encoding HIV gag-pol, the vesicular stomatitis 116 
virus envelope protein G (VSV-G) and the proteins of interest (pWPI-ApoE-BLR, kindly 117 
provided by T Pietschmann; pTRIP-Cerulean-CLDN1, kindly provided CM Rice). Cells were 118 
transduced by overnight incubation with lentiviral pseudoparticles at 37°C. Cells were also 119 
transduced with miR-122-expressing lentiviral particles (miRIDIAN shMIMIC Lentiviral 120 
microRNA, Thermo Scientific) to stably express miR-122 or the non-silencing control 121 
lentiviral particles (miRIDIAN shMIMIC Lentiviral microRNA, Thermo Scientific), as 122 
negative control. 123 
 124 
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2.7 | Western blot analysis. Cells were lysed with RIPA buffer. Protein content of cell 125 
lysates was determined using the BCA protein assay kit (Pierce). The proteins were 126 
precipitated, separated by SDS-PAGE and transferred to Hybond-ECL nitrocellulose 127 
membranes (GE Healthcare). Proteins were detected with specific antibodies diluted 1:1,000 128 
(polyclonal anti-SR-B1 (Santa Cruz, ref sc-67098), polyclonal anti-Occludin (Invitrogen), 129 
polyclonal anti-Claudin 1 (Invitrogen), polyclonal anti-NPC1L1 (Cell Signaling), polyclonal 130 
anti-ApoE (AB947 Millipore) and monoclonal anti-actin (C4, Millipore) and secondary 131 
antibodies conjugated to peroxidase (Sigma-Aldrich). The immune complexes were 132 
visualized by enhanced chemiluminescence detection (ECL; GE Healthcare) as recommended 133 
by the manufacturer. 134 
 135 
2.8 | Quantification of HCV core protein and ApoE. Intracellular or secreted HCV core 136 
antigen was quantified by a fully automated chemiluminescent microparticle immunoassay 137 
(Architect HCVAg; Abbott, Germany), according to the manufacturer’s instructions. 138 
Concentration of human ApoE in the cell culture medium and lysates were determined by a 139 
specific ELISA assay, according to the manufacturer’s instructions (Abcam). 140 
 141 
2.9 | Statistical analysis. Mann-Whitney test was used to compare the results obtained with 142 
the different cell lines to that obtained with HuH-7 cells. Values of p < 0.05 and < 0.01 were 143 
considered as thresholds for significance. 144 
 145 
3 | RESULTS 146 
3.1 | SNU-182, SNU-398 and SNU-449 cells are not permissive to HCV entry and 147 
replication 148 
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 In a previous study, we used the RFP-NLS-IPS HCV infection reporter system (16) 149 
and observed that SNU-182, SNU-398 and SNU-449 cells were not permissive to HCV 150 
infection (13). This result indicated that the entry step and/or the replication step could not be 151 
achieved in these cells. In order to determine which step was affected, we first assessed HCV 152 
entry using HCVpp and pseudoparticles lacking envelope (ΔEnvpp) or non-infected cells as 153 
negative controls. As shown in Figure 1A, we observed that SNU-182 and SNU-449 cells 154 
enable low levels of HCV entry as compared to HuH-7 cells (2.8 103, 2.0 104 and 4.2 105 155 
RLU, respectively) while the results obtained with SNU-398 were similar to that of the 156 
negative controls (2.2 102 RLU). 157 
 We also assessed HCV RNA replication after electroporation of the different cell lines 158 
with a JFH1 replicon expressing a luciferase reporter gene. Similar levels of electroporation 159 
were obtained for each cell line, as measured 4 hours after electroporation (1.5, 0.8, 0.6 and 160 
6.9 105 RLU for HuH-7, SNU-182, SNU-398 and SNU-449, respectively (Figure 1B)). In 161 
contrast, while HuH-7 cells achieved high levels of HCV replication (2.5 107 RLU at 72 h) 162 
the replication levels reached at 72 h in SNU-182, SNU-398 and SNU-449 cells were similar 163 
to that of the background measured in mock electroporated cells (1.0, 0.9 and 4.2 103 RLU at 164 
72 h). Altogether, these results suggested that both the entry and replication steps of HCV life 165 
cycle are blocked in SNU-182, SNU-398 and SNU-449 cells. 166 
 167 
3.2 | Stable expression of miR-122 partly restored HCV RNA replication in SNU-182, 168 
SNU-398 and SNU-449 cells 169 
 Deficiency in miR-122 expression has been shown to be responsible for the absence of 170 
HCV RNA replication in several cell lines (17-20). For this reason, we assessed the 171 
expression of this miRNA by RT-qPCR in SNU-182, SNU-398 and SNU-449 cells. As shown 172 
in Figure 2A, we observed that these three cell lines expressed very low level of miR-122 as 173 
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compared to HuH-7 cells, at least 1000-fold lower. To investigate whether expression of miR-174 
122 could restore HCV RNA replication in these cells, we transduced the miRNA with the 175 
help of lentiviruses. Transduction of 293T cells were used as positive control. While 176 
transduction of a control miRNA (miR-ctrl) had no effect on miR-122 expression, we 177 
observed that SNU-182, SNU-398, SNU-449 and 293T cells transduced with miR-122 178 
express similar level of miR-122 as HuH-7 cells (Figure 2A). As previously demonstrated, we 179 
confirmed that transduction of miR-122 in 293T cells permit to reach similar level of HCV 180 
RNA replication as in HuH-7 cells (2.2 107 and 4.3 107 RLU at 72 h, respectively; Figure 2B). 181 
In contrast, although HCV RNA replication was improved, only low levels were achieved 182 
after miR-122 transduction of SNU-182, SNU-398 and SNU-449 cells, (8.5 105, 2.4 105 and 183 
1.1 105 RLU at 72 h, respectively; Figure 2B). This low level of HCV RNA replication in 184 
SNU-182, SNU-398 and SNU-449 transduced cells was confirmed by the detection of 185 
intracellular Core protein (Figure 2C). Thus, these results indicate that the expression of miR-186 
122 in SNU-182, SNU-398 and SNU-449 improves the replication of HCV RNA but is not 187 
sufficient to achieve high level of replication. 188 
 Recently, it has also been shown that SEC14L2 enables pan-genotype HCV replication 189 
in cell culture (21). We thus investigated whether transduction of SEC14L2 in SNU-182, 190 
SNU-398 and SNU-449 cells could improve HCV replication but we did not observe any 191 
effect (data not shown). However, this result was predictable since Saeed et al. also 192 
mentioned that replication of the JFH-1 strain was not enhanced by SEC14L2. We also 193 
wondered whether induction of the innate immune response could be responsible for the low 194 
replication level, however we did not detect any induction of Interferon- and Interferon- 195 
mRNA expression after infection (data not shown). This was corroborated by the fact that the 196 
use of pyridone-6, an inhibitor of the Janus Kinases involved in the Interferon-mediated 197 
signaling, did not increase the replication level (data not shown).  198 
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 Finally, since low levels of replication were achieved in SNU-182, SNU-398 and 199 
SNU-449 cells transduced with miR-122, we wondered whether they were able to assemble 200 
and secrete progeny virions. However, we did not detect any infectious particle production 201 
(Figure 2D) and levels of extracellular Core protein remained very low or undetectable 202 
(Figure 2C). 203 
 204 
3.3 | CLDN1 transduction improves HCV entry in SNU-182-miR-122 and SNU-398-205 
miR-122 cells 206 
 To understand HCV entry defect in SNU-182, SNU-398 and SNU-449 cells, we 207 
evaluated the expression level of several cellular entry factors. Flow cytometry analysis 208 
revealed that CD81 is correctly expressed at the surface of each cell line (Figure 3A). In 209 
addition, we observed by western blot using specific antibodies that the three cell lines 210 
expressed high levels of SR-BI, OCLN and NPC1L1 (Figure 3B). In contrast, CLDN1 was 211 
only very slightly detected in SNU-182 cells and undetectable in SNU-398 cells. 212 
 Using SNU-182, SNU-398 and SNU-449 cells transduced with miR-122, we 213 
investigated whether stable expression of exogenous CLDN1 could improve HCV entry. 214 
These cells were transduced with lentiviruses expressing Cerulean-CLDN1 and 293T cells 215 
were used as control. The efficiency of the transduction was checked by western blot (Figure 216 
4A) and the effect on HCV entry was evaluated with the help of HCVpp and HCVcc (Figure 217 
4B). These experiments showed that exogenous CLDN1 expression slightly improves HCVpp 218 
entry in SNU-182-miR-122 and SNU-398-miR-122 cells as compared to the increase 219 
observed in 293T cells (8.3-, 5.7- and 64.2-fold increase respectively, as compared to cells 220 
transduced with a control lentivirus). The improvement observed in HCVcc entry was lower, 221 
probably because of the low RNA replication level in these cells, as described above. In 222 
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addition, our results suggest that Cerulean-CLDN1 transduction did not have any effect on 223 
HCV entry in SNU-449-miR-122 cells. 224 
 225 
3.4 | ApoE transduction improves infectious virus production in SNU-182-miR-122-226 
CLDN1 and SNU-398-miR-122-CLDN1 cells 227 
 As shown in Figure 2B and 2D, whereas low levels of HCV RNA replication were 228 
achieved in miR-122 transduced SNU-182, SNU-398 and SNU-449 cells, we did not detect 229 
any production of progeny virions. Since ApoE is known to be essential for assembly and 230 
secretion of new virions, we assessed the expression level of this protein in these cells. 231 
Western blot analysis and ELISA assay suggested that ApoE was not expressed in SNU-398-232 
miR-122-CLDN1 and SNU-449-miR-122 cells whereas it was marginally expressed and 233 
secreted by SNU-182-miR-122-CLDN1 cells. We thus tested whether stable expression of 234 
exogenous ApoE could help these cells to produce infectious virions. After transduction, 235 
ApoE was readily detectable in cell lysates and cell supernatants of SNU-398-miR-122-236 
CLDN1 and SNU-449-miR-122 cells (Figure 5A and 5B). In contrast, while it was readily 237 
detected in the cell lysate of SNU-182-miR-122-CLDN1 cells, the concentration in cell 238 
supernatant was low, suggesting a potential defect in secretion. Interestingly, we observed that 239 
stable expression of ApoE in SNU-182-miR-122-CLDN1 and SNU-398-miR-122-CLDN1 240 
cells gave rise to a production of progeny virions whereas it had no effect on viral production 241 
in SNU-449-miR-122 cells (Figure 5C). These results were confirmed by quantification of 242 
Core in the cell supernatant (Figure 5D). 243 
 244 
4 | DISCUSSION 245 
 In our previous study, we identified three human hepatocellular carcinoma cell lines 246 
established from the primary tumors of Korean patients, SNU-182, SNU-398 and SNU-449, 247 
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that are not permissive to HCV (13). For each cell line, we identified the different steps that 248 
were compromised and tried to decipher the mechanisms of the impairments (cf summary 249 
Table 1). 250 
 We first observed that defect in CLDN1 expression was responsible for the 251 
inefficiency of the entry step in SNU-182 and SNU-398. We also demonstrated that its 252 
ectopic expression render these cells permissive to this step. CLDN1 was identified as an 253 
HCV entry factor thanks to a cyclic lentivirus based repackaging screen of a complementary 254 
DNA library, derived from the highly HCV-permissive hepatocarcinoma Huh-7.5 cell line, 255 
for genes that render the 293T cell line permissive to HCVpp (22). For this reason, 293T cells 256 
are widely used to perform functional studies on the role of CLDN1 in HCV entry. It has also 257 
been shown that CLDN1 expression alone conferred limited permissiveness for HCV 258 
infection in these cells and that co-expression of CD81, OCLN and SR-BI enhance HCV 259 
entry to a level higher than that in Huh7.5.1 cells (20). However, it has to be kept in mind that 260 
many clones of 293T cells exist which may explain some discrepancies between studies. 261 
Other models such as H1H or HuH6 cells have been used (23, 24) and in this study we 262 
identified SNU-182 and SNU-398 cells as alternative cell culture models, expressing high 263 
levels of CD81, OCLN, SR-BI and NPC1L1, to perform functional studies of the role of 264 
CLDN1 in HCV entry. 265 
 MiR-122 is an abundant, liver-specific miRNA that is an unusual host factor for HCV. 266 
This miRNA binds HCV RNA and slows decay of the viral genome through protection from 267 
5' exonuclease activity of the host mRNA decay machinery (25). Many studies demonstrated 268 
that supplementation of several non-permissive cell lines with miR-122 render them 269 
permissive for transient replication of HCV RNA (17-20, 26-28). In this study, we observed 270 
that miR-122 is expressed at a low level in SNU-182, SNU-398 and SNU-449 cells. We also 271 
demonstrated that transduction of this miRNA in these cells improves HCV RNA replication. 272 
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However, in contrast to 293T transduced cells, viral replication in SNU-182, SNU-398 and 273 
SNU-449 cells remained very low even after transduction and this was not due to induction of 274 
innate immune response. It is thus likely that other dependency host factors essential for the 275 
replication are lacking. Alternatively, this could be explained by the presence of restriction 276 
factors that decrease the efficiency of this step. Our results also suggest that transduction of 277 
ApoE permit the production of low level of HCV infectious particles in SNU-182 and SNU-278 
398 cells transduced with miR-122 but not in SNU-449 cells. However, it is difficult to 279 
evaluate precisely the efficiency of this step because of the low level of replication. 280 
 Altogether, our results identified SNU-182, SNU-398 and SNU-449 cells as 281 
hepatocarcinoma cell lines that can be used as models for the study of the functional role of 282 
CLDN1, miR-122 and ApoE in the entry, replication and assembly step of HCV life cycle. 283 
These cell lines could also be used to identify new dependency/restriction host factors 284 
essential for the different step of the viral cycle, thanks to screening strategies, as described 285 
previously (21, 22, 29). 286 
 287 
 288 
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FIGURE LEGENDS 381 
 382 
Figure 1 HCV entry and replication in SNU-182, SNU-398 and SNU-449 cells. A. HuH-7, 383 
SNU-182, SNU-398 and SNU-449 cells were inoculated for 4 h with HCVpp or Δenvpp to 384 
monitor HCV entry. Luciferase assays were performed 48 h post-infection. Results are 385 
expressed as Relative Light Units (RLU) and are reported as the means ± S.D. of three 386 
independent experiments. B. JFH1 RNA encoding a luciferase reporter gene and deleted for 387 
E1E2 region was electroporated in HuH-7, SNU-182, SNU-398 and SNU-449 cells. RNA 388 
Replication was assessed by measuring luciferase activity at 4 and 72 h post-electroporation. 389 
Results are expressed as Relative Light Units (RLU) and are reported as the means ± S.D. of 390 
three independent experiments. Differences were considered statistically significant if 391 
p < 0.05 (*) or p < 0.01 (**). 392 
 393 
Figure 2 Stable expression of miR-122 partly restored HCV RNA replication in SNU-182, 394 
SNU-398 and SNU-449 cells. A. The expression of miR-122 was determined by RT-qPCR in 395 
HuH-7, SNU-182, SNU-398, SNU-449 and 293T cells, before (NT for non-transduced) or 396 
after transduction with lentiviruses expressing a control miRNA (miR-ctrl) or miR-122. The 397 
ΔΔCt method was used for quantification, with the small nuclear RNA RNU6B as 398 
endogenous control and HuH-7 cells as calibrator. All results are representative of 3 399 
independent experiments. B. SNU-182, SNU-398, SNU-449 and 293T cells, transduced with 400 
miR-ctrl or miR-122, were electroporated with JFH1 RNA encoding a luciferase reporter gene. 401 
The replication was assessed by measuring luciferase activities at 4, 24, 48 and 72h. Results 402 
are expressed as RLU and are reported as means ± S.D. of three independent experiments. C. 403 
Core protein concentration was determined in the cell culture supernatants and the cell lysates 404 
recovered 72h post-electroporation. Results are reported as the means ± S.D. of three 405 
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independent experiments (ND : not determined). D. Infectious particle production was 406 
evaluated after inoculation of naive HuH-7 cells with the supernatants recovered from 407 
electroporated cells. HuH-7 cells were inoculated during 4 h and luciferase activities were 408 
measured 72 h post-infection. Results are expressed as RLU and are reported as the means ± 409 
S.D. of three independents experiment. Differences were considered statistically significant if 410 
p < 0.05 (*) or p < 0.01 (**). 411 
 412 
Figure 3 Evaluation of HCV cell entry factor expression in SNU-182, SNU-398 and SNU-413 
449 cells. A. Flow cytometry was performed to assess the expression of CD81 in SNU-182, 414 
SNU-398, and SNU-449, using FITC-coupled anti-CD81 antibody (grey) or isotype control 415 
(white). HuH-7 cells were used as control. B. SR-B1, CLDN1, OCLN and NPC1L1 416 
expression in each cell line was evaluated by western blot. -actin served as a loading control. 417 
The molecular weight (MW) of each protein is indicated on the left. 418 
 419 
Figure 4 Ectopic expression of CLDN1 in SNU-182-miR-122 and SNU-398-miR-122 cells 420 
improves HCV entry. A. SNU-182-miR-122, SNU-398-miR-122, SNU-449-miR-122 and 421 
293T cells were transduced with lentiviruses expressing Cerulean-CLDN1. Empty 422 
lentiviruses were used as negative control. Cerulean-CLDN1 expression was evaluated by 423 
western blot. -actin served as a loading control. The molecular weight (MW) of each protein 424 
is indicated on the left. B. HCV entry in each cell line was evaluated after inoculation with 425 
HCVpp or HCVcc for 4 h. 293T cells were used as control. Infection was determined by 426 
measuring luciferase activities 72h post-infection. Results are expressed as RLU and are 427 
reported as the means ± S.D. of three independent experiments. Differences were considered 428 
statistically significant if p < 0.05 (*) or p < 0.01 (**). 429 
 430 
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Figure 5 Ectopic expression of ApoE enables HCVcc production in the SNU182-miR-122-431 
CLDN-1 and SNU398-miR-122-CLDN-1 cells. A. SNU-182-miR-122-CLDN1, SNU-398-432 
miR-122-CLDN1 cells and SNU-449-miR-122 cells were transduced with lentiviruses 433 
expressing ApoE. HuH-7 and 293T-miR122-CLDN1 cells were used as control. Non-434 
transduced cells were used as negative control. ApoE expression was evaluated by western 435 
blot. -actin served as a loading control. The molecular weight (MW) of each protein is 436 
indicated on the left. B. The concentration of ApoE secreted in the supernatant of each cell 437 
line after 72 h was evaluated by Elisa assay. Results are reported as the means ± S.D. of two 438 
independent experiments. C. The different cell lines were electroporated with JFH1 RNA 439 
encoding a luciferase reporter gene and the supernatants were recovered 72 h after 440 
electroporation. Infectious particle production was evaluated by inoculating naive HuH-7 cells 441 
with these supernatants for 4 h and measuring luciferase activities 72 h post-infection. Results 442 
are expressed as RLU and are reported as the means ± S.D. of three independent experiments. 443 
D. Core protein concentration in the cell culture supernatants and the cell lysates was 444 
determined 72h post-electroporation. Results are reported as the means ± S.D. of at least two 445 
independent experiments. Differences were considered statistically significant if p < 0.05 (*) 446 
or p < 0.01 (**). 447 
 448 
 449 
 450 
 451 
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TABLE 1 Features of the cell lines used in this study 
 
Cell line Entry Replication Assembly CD81 SR-BI CLDN1 OCLN NPC1L1 mir-122 ApoE 
HuH-7 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
SNU-182 +/- - - ++ ++ +/- ++ ++ - + 
SNU-182-miR122 +/- + - ++ ++ +/- ++ ++ ++ + 
SNU-182-miR-122-CLDN1 + + - ++ ++ ++ ++ ++ ++ + 
SNU-182-miR-122-CLDN1-ApoE + + + ++ ++ ++ ++ ++ ++ ++ 
SNU-398 - - - ++ ++ - ++ ++ - - 
SNU-398-miR122 - + - ++ ++ - ++ ++ ++ - 
SNU-398-miR-122-CLDN1 + + - ++ ++ ++ ++ ++ ++ - 
SNU-398-miR-122-CLDN1-ApoE + + + ++ ++ ++ ++ ++ ++ ++ 
SNU-449 + - - ++ ++ + ++ ++ - - 
SNU-449-miR122 + + - ++ ++ + ++ ++ ++ - 
SNU-449-miR-122-CLDN1 + + - ++ ++ ++ ++ ++ ++ - 
SNU-449-miR-122-ApoE + + - ++ ++ + ++ ++ ++ ++ 
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